JOURNAL
Current Issue
Journal Archive
 

Chief Editor -
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE

.........................................................

Publisher -
Lesley Pocock
medi+WORLD International
AUSTRALIA
Email
: lesleypocock@mediworld.com.au
publishermwi@gmail.com
.........................................................

Editorial Enquiries -
abyad@cyberia.net.lb
.........................................................

Advertising Enquiries -
lesleypocock@mediworld.com.au
.........................................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.

WFM / MEJFM January/February 2025

Intermittent Fasting and glycaemic control in Type II Diabetes: A review


Ikram Olol (1), Lina Zbaidi (1)

(1) Family Medicine Consultant, Primary Health Care Corporation , Qatar

Corresponding author:
Dr Ikram Olol
Family Medicine Consultant
Primary Health Care Corporation
Qatar
Email: ikram12345@doctors.net.uk

Received: November 2024. Accepted: December 2024; Published: January / February, 2025.Citation: Ikram Olol, Lina Zbaidi. Intermittent Fasting and glycaemic control in Type II Diabetes: A review. World Family Medicine. January/February 2025; 23(1): 33-35. DOI: 10.5742/MEWFM.2025.95257875


Abstract

This paper reviews the impact of intermittent fasting on glycaemic control and subsequently Type 2 diabetes.Type 2 Diabetes has been labelled a disease of modern lifestyle causing significant health burden on individuals and overall health care systems. Research highlights that poor glycaemic control can lead to insulin resistance, metabolic syndrome and potentially Type 2 Diabetes. Periodic calorific restriction is hypothesized to reduce insulin resistance and increased lipolysis. Intermittent fasting can cause a risk of hypoglycaemia and dietary measures alone may not be sufficient for weightloss and Type 2 Diabetes management.

Key words: Type 2 Diabetes, Intermittent Fasting, Glycaemic Control,Weight Loss





.................................................................................................................

I About MEJFM I Journal I Advertising I Author Info I Editorial Board I Resources I Contact us I Journal Archive I MEPRCN I Noticeboard I News and Updates
Disclaimer - ISSN 148-4196 - © Copyright 2007 medi+WORLD International Pty. Ltd. - All rights reserved